Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

Evaluation of histone deacetylase inhibitors as therapeutics for neurodegenerative diseases

Various neurodegenerative diseases are associated with aberrant gene expression. We recently identified a novel class of pimelic o-aminobenzamide histone deacetylase (HDAC) inhibitors that show promise as therapeutics in the neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's disease (HD). 

Evaluation of histone deacetylase inhibitors as therapeutics for neurodegenerative diseases


About the Author

Jen Farmer

Jen Farmer

Executive Director

SHARE

FacebookTwitterLinkedinShare on Google+
Event I.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News